Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-005730
Filing Date
2025-02-26
Accepted
2025-02-26 18:52:05
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 form4-02262025_110201.html 4  
1 form4-02262025_110201.xml 4 4986
  Complete submission text file 0001415889-25-005730.txt   6514
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address
Aslam Shakil (Reporting) CIK: 0002040805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 25672047